PROPANC BIOPHARMA, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | $-409.4K | — |
| FY2010 | — | $-186.9K | — |
| FY2011 | — | $10.5M | $132 |
| FY2012 | — | $-537.9K | $179 |
| FY2013 | — | $-792.5K | $0 |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | $-409.4K | — |
| FY2010 | — | $-186.9K | — |
| FY2011 | — | $10.5M | $132 |
| FY2012 | — | $-537.9K | $179 |
| FY2013 | — | $-792.5K | $0 |